Tag Archives: Trial

Moderna’s COVID-19 vaccine aces trial in teens, teeing up back-to-school FDA approval

Teens across the U.S. started getting COVID-19 vaccines this month after Pfizer’s shot. With new data released Tuesday, Moderna’s shot could soon be available to kids, too. In a phase 3 trial in kids ages 12 to 18, Moderna’s vaccine posted 100% efficacy after two doses. Investigators enrolled 3,700 participants and randomly assigned two-thirds to receive two doses of… Read More »

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

‘Unexpected finding’ killed vaccine trial

Prime Minister Scott Morrison announced on Friday it has terminated its $ 1 billion deal for the vaccine candidate being developed by the University of Queensland (UQ) and global biotech company CSL because trial participants were returning false-positive HIV test results. There were fears these results could undermine confidence in other vaccine candidates, so the… Read More »

CureVac COVID-19 Vaccine Induces Immune Response in Early Trial

Berlin, November 2: German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered immune response among volunteers. The vaccine candidate was generally well tolerated across all tested doses and induced strong binding and neutralising antibody responses in addition to first… Read More »

Covid-19 news: Russian vaccine induced immune responses in small trial

By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Sputnik V, Gamaleya National CenterTHE RUSSIAN DIRECT INVESTMENT FUND Latest coronavirus news as of 5 pm on 4 September Russia’s vaccine candidate produced antibody and T-cell responses in early-stage trial A preliminary trial of Russia’s coronavirus… Read More »